Delivery Order SPE2DE21D0044-SPE2D625F01YK

Award Date 12/20/24
Potential Completion Date 12/30/24
Potential Value $25K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Essex Junction, VT, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DE21D0044
    Indefinite Delivery Contract
  • SPE2DE21D0044-SPE2D625F01YK
    Delivery Order

This is a federal contract award to Revision Military LIMITED, a manufacturer of protective equipment specializing in ballistic and laser protective eyewear, helmets, and other gear for military, law enforcement, and tactical clients. The contract, worth $24,876.00, is a delivery order awarded by the Defense Logistics Agency Troop Support Medical for the procurement of Ultra Performance Liquid Chromatography (UPLC) units. Revision Military LIMITED has previously received multiple delivery orders from the agency for various specialized medical equipment. Additionally, the company has secured larger contracts from the Department of the Army Materiel Command Research Development and Engineering Command for research and development projects related to integrated sound, light, and blast management for ears and eyes, as well as the development of laser eye protection goggles and kits. Revision Military LIMITED also holds two significant Other Transaction Agreement (OTA) Indefinite Delivery Vehicles (IDVs) with the Department of the Army Materiel Command Research Development and Engineering Command, focused on the development of enhanced ballistic spectacle and visor prototypes to support soldier protection and survivability efforts. This contract does not have a set-aside designation.

Generated 3/21/25, 9:54 AM